Alexander Ploss finals in the SC QED Proof-of-Concept Program

Grants, Fellowships and Awards
Posted on July 15, 2020
Alexander Ploss, Associate Professor of Molecular Biology

Princeton University is the QED program’s newest participating institution. The 12 researchers will be paired with business advisors made up of industry professionals and serial entrepreneurs to develop a proof-of-concept plan. Finalists will present those plans to the selection committee later this year with the awardees announced in early 2021.  

Each of the technologies were identified as having high potential for improving human health and of being of intense industry and investor interest. Since its inception in 2009, the QED program has provided development services for over 100 academic researchers with over $8M invested in 41 projects.  Twelve startups or licensing deals have resulted. 

The Science Center’s commercialization programs, of which QED is part, is a leader in the development of biotechnology across the region. Equipped with deep expertise both in-house and in its network of advisors, the Science Center can efficiently identify, evaluate, accelerate, and finance the most promising life science ideas and businesses.  The Science Center’s first-hand research, startup, and investment experience and its expanding set of analytical tools are used not only by academia but increasingly by industry partners seeking to simplify scouting operations around licensing, mergers and acquisitions, investment, and out-sourced technology incubation.